Synopsis
Use inferior vena cava filters only for narrow evidence-based indications, pair every placement with an anticoagulation and retrieval plan, and prevent avoidable long-dwell complications.
- Do not offer an IVC filter routinely for proximal DVT or PE; consider it when therapeutic anticoagulation is genuinely contraindicated.
- If PE occurs during anticoagulation, complete the treatment-failure sequence—confirm recurrence, check adherence and exposure, address hypercoagulability, then intensify or change therapy—before considering a filter.
- Before insertion, choose a retrievable device when the indication may resolve and write an earliest-possible retrieval strategy with a named owner and review date.
Key red flags
Ongoing major bleeding, recent critical-site haemorrhage or an urgent operation may create a genuine temporary inability to anticoagulate acute proximal DVT or PE.
New PE during prescribed anticoagulation requires objective confirmation and an immediate treatment-exposure review before calling it failure.
New bilateral leg swelling, abdominal or back pain, renal dysfunction or venous claudication after placement can signal filter or caval thrombosis.
Chest pain or collapse after filter placement may represent recurrent PE, migration, fracture or another acute diagnosis and needs urgent assessment.
Investigation priorities
Confirm the disease and distinguish new embolism from residual previous thrombus.
Management branches
Proximal DVT or PE is objectively confirmed and therapeutic anticoagulation is temporarily unsafe.
- Define and treat the specific contraindication, estimate when it may resolve, and obtain thrombosis plus interventional input rather than using a vague “high bleeding risk” label.
- Consider a retrievable IVC filter, documenting device, indication, intended duration, named follow-up owner and earliest retrieval review before insertion.
New PE is objectively demonstrated while the patient is believed to be receiving therapeutic anticoagulant treatment.